Are you Dr. Naqash?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 12 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
800 NE 10th St
Oklahoma City, OK 73104Phone+1 405-271-8001
Summary
- Dr. AbdulRafeh Naqash, MD is an oncologist in Oklahoma City, Oklahoma. He is currently licensed to practice medicine in Oklahoma and North Carolina. He is affiliated with OU Health.
Education & Training
- Government Medical College of Jammu and KashmireClass of 2012
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- OK State Medical License 2021 - 2025
- NC State Medical License 2017 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Unraveling the link between cholesterol and immune system in cancer: from biological mechanistic insights to clinical evidence. A narrative review.Federica Pecci, Valeria Cognigni, Giulia Claire Giudice, Francesco Paoloni, Luca Cantini
Critical Reviews in Oncology/hematology. 2025-02-07 - Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembr...Alessio Cortellini, Leonardo Brunetti, Giuseppina Rita Di Fazio, Edoardo Garbo, David J Pinato
Journal for Immunotherapy of Cancer. 2025-02-04 - Activity of Platinum Chemotherapy in Men With Prostate Cancer With and Without DNA Damage Repair Mutations.Stephanie Lakritz, Andrew Nicklawsky, Vida Alami, Manish Kohli, Chris Moskaluk
Clinical Genitourinary Cancer. 2025-02-01
Press Mentions
- Oklahoma Bio-Medical Science Teacher Enrolls in Phase I Clinical Trial After Cancer DiagnosisAugust 15th, 2024